FDA Approval History
This list consists of medications tracked by Drugs.com through the application and approval process at the U.S. Food and Drug Administration (FDA). Where possible, we have assembled information in chronological order to show the history of a medication. May only show partial information and does not include non-US drug approvals. For information about non-US medications, please visit the international drugs section.
Latest drug approvals
- Ebglyss (lebrikizumab-lbkz) - September 13, 2024
- Ocrevus Zunovo (ocrelizumab & hyaluronidase-ocsq) - September 13, 2024
- Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) - September 12, 2024
- Boruzu (bortezomib) - September 05, 2024
- Pavblu (aflibercept-ayyh) - August 23, 2024
- Lazcluze (lazertinib) - August 20, 2024
- Livdelzi (seladelpar) - August 14, 2024
- Niktimvo (axatilimab-csfr) - August 14, 2024
- Nemluvio (nemolizumab) - August 12, 2024
- Enzeevu (aflibercept-abzv) - August 09, 2024
- Neffy (epinephrine) - August 09, 2024
- Yorvipath (palopegteriparatide) - August 09, 2024
- Crexont (carbidopa and levodopa) - August 07, 2024
- Lymphir (denileukin diftitox-cxdl) - August 07, 2024
- Zurnai (nalmefene hydrochloride) - August 07, 2024
- Voranigo (vorasidenib) - August 06, 2024
- Tecelra (afamitresgene autoleucel) - August 01, 2024
- Erzofri (paliperidone palmitate) - July 26, 2024
- Zunveyl (benzgalantamine) - July 26, 2024
- Leqselvi (deuruxolitinib phosphate) - July 25, 2024